225 related articles for article (PubMed ID: 35562412)
41. Inferior outcomes of stage III T lymphoblastic lymphoma relative to stage IV lymphoma and T-acute lymphoblastic leukemia: long-term comparison of outcomes in the JACLS NHL T-98 and ALL T-97 protocols.
Kobayashi R; Takimoto T; Nakazawa A; Fujita N; Akazai A; Yamato K; Yazaki M; Deguchi T; Hashii Y; Kato K; Hatakeyama N; Horibe K; Hori H; Oda M;
Int J Hematol; 2014 Jun; 99(6):743-9. PubMed ID: 24803201
[TBL] [Abstract][Full Text] [Related]
42. Complete Blood Count Score Model Integrating Reduced Lymphocyte-Monocyte Ratio, Elevated Neutrophil-Lymphocyte Ratio, and Elevated Platelet-Lymphocyte Ratio Predicts Inferior Clinical Outcomes in Adult T-Lymphoblastic Lymphoma.
Feng X; Li L; Wu J; Zhang L; Sun Z; Li X; Wang X; Yu H; Chang Y; Wu X; Zhou Z; Wang G; Li W; Li Z; Zhang X; Zhang M
Oncologist; 2019 Nov; 24(11):e1123-e1131. PubMed ID: 30952822
[TBL] [Abstract][Full Text] [Related]
43. [Expression of miR-16 in patients with T lymphoblastic lymphoma/acute lymphoblastic leukemia].
Tong LG; Wu WZ; Zhang YP; Zhou ZG; Chen YF; Huang WJ; Xu H; Su QQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):99-103. PubMed ID: 24598659
[TBL] [Abstract][Full Text] [Related]
44. Is there a difference in childhood T-cell acute lymphoblastic leukaemia and T-cell lymphoblastic lymphoma?
Uyttebroeck A; Vanhentenrijk V; Hagemeijer A; Boeckx N; Renard M; Wlodarska I; Vandenberghe P; Depaepe P; De Wolf-Peeters C
Leuk Lymphoma; 2007 Sep; 48(9):1745-54. PubMed ID: 17786710
[TBL] [Abstract][Full Text] [Related]
45. Paediatric lymphoblastic T-cell leukaemia and lymphoma: one or two diseases?
Burkhardt B
Br J Haematol; 2010 Jun; 149(5):653-68. PubMed ID: 19961482
[TBL] [Abstract][Full Text] [Related]
46. [Clinicopathologic features and prognosis of T lymphoblastic lymphoma associated with Langerhans cell histiocytosis].
Li X; Wang Y; Chen R; Abulaiti D; Ma Z; Miao N; Abulajiang G; Zhang W
Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):522-7. PubMed ID: 25346121
[TBL] [Abstract][Full Text] [Related]
47. FAS system deregulation in T-cell lymphoblastic lymphoma.
Villa-Morales M; Cobos MA; González-Gugel E; Álvarez-Iglesias V; Martínez B; Piris MA; Carracedo A; Benítez J; Fernández-Piqueras J
Cell Death Dis; 2014 Mar; 5(3):e1110. PubMed ID: 24603338
[TBL] [Abstract][Full Text] [Related]
48. Expression and significance of CD47, PD1 and PDL1 in T-cell acute lymphoblastic lymphoma/leukemia.
Yang K; Xu J; Liu Q; Li J; Xi Y
Pathol Res Pract; 2019 Feb; 215(2):265-271. PubMed ID: 30466764
[TBL] [Abstract][Full Text] [Related]
49. Diagnostic challenges in T-lymphoblastic lymphoma, early T-cell precursor acute lymphoblastic leukemia or mixed phenotype acute leukemia: A case report.
Wang P; Peng X; Deng X; Gao L; Zhang X; Feng Y
Medicine (Baltimore); 2018 Oct; 97(41):e12743. PubMed ID: 30313079
[TBL] [Abstract][Full Text] [Related]
50. Lymphoblastic Lymphoma: a Concise Review.
Intermesoli T; Weber A; Leoncin M; Frison L; Skert C; Bassan R
Curr Oncol Rep; 2022 Jan; 24(1):1-12. PubMed ID: 35059993
[TBL] [Abstract][Full Text] [Related]
51. [Expression of βF1 and T cell receptor γ in T lymphoblastic lymphoma/leukemia].
Zhang F; Luo DL; Chen Y; Wu HM; Yan JH; Luo XL; He J; Luo LQ; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2018 Feb; 47(2):119-122. PubMed ID: 29429164
[No Abstract] [Full Text] [Related]
52. Methylation status of cyclin-dependent kinase inhibitor genes within the transforming growth factor beta pathway in human T-cell lymphoblastic lymphoma/leukemia.
Scott SA; Kimura T; Dong WF; Ichinohasama R; Bergen S; Kerviche A; Sheridan D; DeCoteau JF
Leuk Res; 2004 Dec; 28(12):1293-301. PubMed ID: 15475071
[TBL] [Abstract][Full Text] [Related]
53. Targeting hyperactive platelet-derived growth factor receptor-β signaling in T-cell acute lymphoblastic leukemia and lymphoma.
De Coninck S; De Smedt R; Lintermans B; Reunes L; Kosasih HJ; Reekmans A; Brown LM; Van Roy N; Palhais B; Roels J; Van der Linden M; Van Dorpe J; Ntziachristos P; Van Delft FW; Mansour MR; Pieters T; Lammens T; De Moerloose B; De Bock CE; Goossens S; Van Vlierberghe P
Haematologica; 2024 May; 109(5):1373-1384. PubMed ID: 37941480
[TBL] [Abstract][Full Text] [Related]
54. Relapsed or Refractory Lymphoblastic Lymphoma in Children: Results and Analysis of 23 Patients in the EORTC 58951 and the LMT96 Protocols.
Michaux K; Bergeron C; Gandemer V; Mechinaud F; Uyttebroeck A; Bertrand Y;
Pediatr Blood Cancer; 2016 Jul; 63(7):1214-21. PubMed ID: 27037853
[TBL] [Abstract][Full Text] [Related]
55. FIP1L1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.
Ali S; Al-Qattan Y; Awny W; Hamadah A; Pinto K; AlShemmari S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1769. PubMed ID: 36517458
[TBL] [Abstract][Full Text] [Related]
56. Recent developments in the management of T-cell precursor acute lymphoblastic leukemia/lymphoma.
Fielding AK; Banerjee L; Marks DI
Curr Hematol Malig Rep; 2012 Jun; 7(2):160-9. PubMed ID: 22476945
[TBL] [Abstract][Full Text] [Related]
57. Digital Multiplex Ligation-Dependent Probe Amplification for Detection of Key Copy Number Alterations in T- and B-Cell Lymphoblastic Leukemia.
Benard-Slagter A; Zondervan I; de Groot K; Ghazavi F; Sarhadi V; Van Vlierberghe P; De Moerloose B; Schwab C; Vettenranta K; Harrison CJ; Knuutila S; Schouten J; Lammens T; Savola S
J Mol Diagn; 2017 Sep; 19(5):659-672. PubMed ID: 28736295
[TBL] [Abstract][Full Text] [Related]
58. Poor outcome for children and adolescents with progressive disease or relapse of lymphoblastic lymphoma: a report from the berlin-frankfurt-muenster group.
Burkhardt B; Reiter A; Landmann E; Lang P; Lassay L; Dickerhoff R; Lakomek M; Henze G; von Stackelberg A
J Clin Oncol; 2009 Jul; 27(20):3363-9. PubMed ID: 19433688
[TBL] [Abstract][Full Text] [Related]
59. 3D genome alterations associated with dysregulated HOXA13 expression in high-risk T-lineage acute lymphoblastic leukemia.
Yang L; Chen F; Zhu H; Chen Y; Dong B; Shi M; Wang W; Jiang Q; Zhang L; Huang X; Zhang MQ; Wu H
Nat Commun; 2021 Jun; 12(1):3708. PubMed ID: 34140506
[TBL] [Abstract][Full Text] [Related]
60. Overexpression of the shortest isoform of histone demethylase LSD1 primes hematopoietic stem cells for malignant transformation.
Wada T; Koyama D; Kikuchi J; Honda H; Furukawa Y
Blood; 2015 Jun; 125(24):3731-46. PubMed ID: 25904247
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
